{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T18:50:15Z","timestamp":1782586215510,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.humpath.2023.06.012","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T11:42:28Z","timestamp":1688038948000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics"],"prefix":"10.1016","volume":"139","author":[{"given":"Jeffrey M.","family":"Cloutier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Kunder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Allard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Krings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Charville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2866-8283","authenticated-orcid":false,"given":"Gregory R.","family":"Bean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2023.06.012_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/ajcp\/88.5.615","article-title":"Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance","volume":"88","author":"Evans","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/PAS.0b013e31822b3687","article-title":"Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up","volume":"35","author":"Evans","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000478-199306000-00007","article-title":"Low-grade fibromyxoid sarcoma. A report of 12 cases","volume":"17","author":"Evans","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2559.1995.tb01436.x","article-title":"Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity","volume":"26","author":"Goodlad","year":"1995","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.06.012_bib5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/PAS.0b013e318210c268","article-title":"MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma","volume":"35","author":"Doyle","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/gcc.20037","article-title":"The chimeric FUS\/CREB3L2 gene is specific for low-grade fibromyxoid sarcoma","volume":"40","author":"Panagopoulos","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2023.06.012_bib7","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/hmg\/ddg237","article-title":"Fusion of the FUS and BBF2H7 genes in low grade fibromyxoid sarcoma","volume":"12","author":"Storlazzi","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.humpath.2023.06.012_bib8","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/01.pas.0000209830.24230.1f","article-title":"Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens","volume":"30","author":"Matsuyama","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/labinvest.3700230","article-title":"Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS\/CREB3L1 fusion gene","volume":"85","author":"Mertens","year":"2005","journal-title":"Lab Invest"},{"key":"10.1016\/j.humpath.2023.06.012_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PAS.0b013e3181578d5a","article-title":"The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms","volume":"32","author":"Downs-Kelly","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/PAS.0b013e31827560f8","article-title":"EWSR1-CREB3L1 gene fusion: a novel alternative molecular aberration of low-grade fibromyxoid sarcoma","volume":"37","author":"Lau","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.humpath.2018.02.013","article-title":"Primary low-grade fibromyxoid sarcoma of the breast: a rare case report with immunohistochemical and fluorescence in situ hybridization detection","volume":"79","author":"Zhang","year":"2018","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib13","first-page":"5860","article-title":"Low-grade fibromyxoid sarcoma: a clinicopathologic and molecular study of 10 genetically confirmed cases","volume":"11","author":"Li","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib14","first-page":"724","article-title":"Low-grade fibromyxoid sarcoma of a male breast: a uniquely rare case report","volume":"131","author":"Niepok\u00f3j-Czopnik","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.humpath.2023.06.012_bib15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.humpath.2023.06.012_bib16","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/00000478-200010000-00004","article-title":"Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas","volume":"24","author":"Folpe","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib17","first-page":"239","article-title":"Low-grade fibromyxoid sarcoma: treatment outcomes and efficacy of chemotherapy","volume":"34","author":"Chamberlain","year":"2020","journal-title":"In\u00a0Vivo"},{"key":"10.1016\/j.humpath.2023.06.012_bib18","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/00000478-199712000-00011","article-title":"Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma","volume":"21","author":"Lane","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib19","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1097\/PAS.0b013e3180321959","volume":"31","author":"Guillou","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.anndiagpath.2011.02.005","article-title":"Low-grade fibromyxoid sarcoma: a clinicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases","volume":"15","author":"Rekhi","year":"2011","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/modpathol.2011.214","article-title":"FUS rearrangements are rare in \u2018pure\u2019 sclerosing epithelioid fibrosarcoma","volume":"25","author":"Wang","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/PAS.0b013e3182562bf8","article-title":"MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement","volume":"36","author":"Doyle","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/gcc.22215","article-title":"A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF\/low grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases","volume":"54","author":"Prieto-Granada","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2023.06.012_bib24","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/PAS.0000000000000158","article-title":"Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma","volume":"38","author":"Arbajian","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4322\/acr.2013.024","article-title":"Fibrosarcoma: a challenging diagnosis","volume":"3","author":"Ferreira","year":"2013","journal-title":"Autopsy Case Rep"},{"key":"10.1016\/j.humpath.2023.06.012_bib26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAI.0000000000000816","article-title":"MUC4 expression in angiomatoid fibrous histiocytoma","volume":"28","author":"Abrahao-Machado","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.humpath.2023.06.012_bib27","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/his.12422","article-title":"MUC 4-negative FUS\u2013CREB3L2 rearranged low-grade fibromyxoid sarcoma","volume":"65","author":"Linos","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.06.012_bib28","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1096\/fj.07-9673rev","article-title":"Structure, evolution, and biology of the MUC4 mucin","volume":"22","author":"Chaturvedi","year":"2008","journal-title":"Faseb J"},{"key":"10.1016\/j.humpath.2023.06.012_bib29","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/modpathol.2017.32","article-title":"Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas","volume":"30","author":"Krings","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/his.13779","article-title":"CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast","volume":"74","author":"Bean","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2023.06.012_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/gcc.22335","article-title":"Gene fusions in soft tissue tumors: recurrent and overlapping pathogenetic themes","volume":"55","author":"Mertens","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2023.06.012_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12105-015-0647-8","article-title":"Low-grade fibromyxoid sarcoma of the head and neck: a clinicopathologic series and review of the literature","volume":"10","author":"Cowan","year":"2015","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2023.06.012_bib33","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1309\/AJCPXNUC7JZSKWEU","article-title":"p63 immunohistochemical staining is limited in soft tissue tumors","volume":"136","author":"Jo","year":"2011","journal-title":"Am J Clin Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723001454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817723001454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:41:15Z","timestamp":1758645675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817723001454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":33,"alternative-id":["S0046817723001454"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2023.06.012","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2023.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}